US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

43.29

+0.03220.07%

Post-market: 43.290.00000.00%16:15 EDT

Volume:17.37K

Turnover:755.83K

Market Cap:41.12M

PE:- -

High:44.03

Open:42.82

Low:42.82

Close:43.26

52wk High:56.18

52wk Low:27.62

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.86

T/O Rate:1.83%

Dividend:0.65

Dividend Rate:1.51%

ROE:--

ROA:--

PB:0.93

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Press Release: Trasteel Holding S.A. Completes Acquisition of the Remaining 40% Interest in BBC Alloys S.r.l.

Mirum Advances MRM-3379 With Completed Phase 1 ADME Study

Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)

ArriVent says Phase 3 firmonertinib trial did not meet endpoint

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BBC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":43.2874,"timestamp":1791403200000,"preClose":43.2552,"halted":0,"volume":17369,"hourTrading":{"tag":"盘后","latestPrice":43.2874,"preClose":43.2874,"latestTime":"16:15 EDT","volume":12,"amount":519.426636,"timestamp":1791404100369,"change":0,"changeRate":0,"amplitude":0.000171},"delay":0,"changeRate":0.000744419168099928,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Post-Mkt","change":0.0322,"latestTime":"10-07 17:01:21 EDT","open":42.82,"high":44.03,"low":42.82,"amount":755831,"amplitude":0.027974,"askPrice":51.01,"askSize":100,"bidPrice":29.64,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":43.2552,"sharesOutstanding":900004,"nav":44.728,"aum":42491680.3,"dividendRate":0.01509,"bidAskSpread":0.002127,"postHourTrading":{"tag":"盘后","latestPrice":43.2874,"preClose":43.2874,"latestTime":"16:15 EDT","volume":12,"amount":519.426636,"timestamp":1791404100369,"change":0,"changeRate":0,"amplitude":0.000171},"volumeRatio":0.863082,"impliedVol":0.371,"impliedVolPercentile":0.8207},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.863082,"shares":950000,"dividePrice":0.6532,"high":44.03,"amplitude":0.027974,"preClose":43.2552,"low":42.82,"week52Low":27.62,"pbRate":"0.93","week52High":56.18,"institutionHeld":0,"latestPrice":43.2874,"eps":0,"divideRate":0.01509,"volume":17369,"delay":0,"ttmEps":0,"open":42.82,"prevYearClose":38.56,"prevWeekClose":44.5638,"prevMonthClose":46.2948,"prevQuarterClose":46.2948,"fiveDayClose":46.2948,"twentyDayClose":51.51,"sixtyDayClose":51.5732},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673101280","title":"Press Release: Trasteel Holding S.A. Completes Acquisition of the Remaining 40% Interest in BBC Alloys S.r.l.","url":"https://stock-news.laohu8.com/highlight/detail?id=2673101280","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673101280?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:05","pubTimestamp":1791403500,"startTime":"0","endTime":"0","summary":"LUGANO, Switzerland and BERTRANGE, Luxembourg, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Trasteel Holding S.A. (\"Trasteel\" or the \"Company\"), a global steel trading and industrial group (the \"Group\") headquar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC","SZZL","CEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011746","title":"Mirum Advances MRM-3379 With Completed Phase 1 ADME Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011746","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011746?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:30","pubTimestamp":1791390610,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical study. Mirum Pharmaceuticals, Inc. is running a Phase 1 trial called “A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mirum-advances-mrm-3379-with-completed-phase-1-adme-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mirum-advances-mrm-3379-with-completed-phase-1-adme-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRM","ADME","BBC","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673656016","title":"Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673656016","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673656016?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:00","pubTimestamp":1791381622,"startTime":"0","endTime":"0","summary":"WSW, NY, October 7th, 2026, FinanceWire The former Gilead and Amgen commercial leader takes her seat as Entera’s Phase 3 trial nears its init...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/former-gilead-and-amgen-commercial-leader-laura-hamill-just-joined-entera-nasdaq-entx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/former-gilead-and-amgen-commercial-leader-laura-hamill-just-joined-entera-nasdaq-entx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TQQQ","NQmain","PSQ","LU1983299246.USD","ONEQ","SQQQ","LU0320765992.SGD","TBXU","IE00BFTCPJ56.SGD","QID","03086",".IXIC","TQQY","LU0122379950.USD","LU0889565916.HKD","NVIW.SI","QLD","BK4534","QQQJ","BK4599","QQQ","QQQE","AMGN","TECS","IYW","JEPQ","IE0002141913.USD","BK4139","PSIL","PJP","PBE","BBH","MNQmain","QQQA","QQQM","QYLG","ENTX","BBC","BIB","BK4566","LU1057294990.SGD","FTEC","IBBQ","QQQY","IE00BJT1NW94.SGD","IBB","IE0009355771.USD","QDTE","GPIQ","NDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051961","title":"ArriVent says Phase 3 firmonertinib trial did not meet endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051961","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051961?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:13","pubTimestamp":1791292413,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) announced that the FURVENT Phase 3 trial evaluating firmonertinib monotherapy in patients with previously untreated, loca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrivent-says-phase-3-firmonertinib-trial-did-not-meet-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrivent-says-phase-3-firmonertinib-trial-did-not-meet-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","AVBP","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":42,"pageCount":1,"totalSize":167,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBC\",params:#limit:6,delay:false,,,undefined,":[]}}